ALB and atrial fibrillation: AF-albumin was used to assess the efficacy of the intervention, and by the second month the relative change on the high dose intervention, compared to the baseline, was significantly greater than in the placebo (P < 0.001), but no significant difference was observed for the low intervention compared to control [111].